Relationship between triglyceride-glucose index and aminotransferase among Royal Thai Army personnel 2017–2021: a serial cross-sectional study

Denova-Gutiérrez E, Lara-Castor L, Hernández-Alcaraz C, Hernández-Ávila M, Aguilar-Salinas C, Kershenobich D, et al. Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016. Ann Hepatol. 2021;26:100562.

Article  PubMed  Google Scholar 

Wong S-W, Chan W-K. Epidemiology of non-alcoholic fatty liver disease in Asia. Indian J Gastroenterol. 2020;39:1–8.

Article  PubMed  Google Scholar 

Beran A, Ayesh H, Mhanna M, Wahood W, Ghazaleh S, Abuhelwa Z, et al. Triglyceride-glucose index for early prediction of nonalcoholic fatty liver disease: a meta-analysis of 121,975 individuals. J Clin Med. 2022;11:2666.

Article  PubMed  PubMed Central  Google Scholar 

Hadavi M, Najdegerami EH, Nikoo M, Nejati V. Protective effect of protein hydrolysates from Litopenaeus vannamei waste on oxidative status, glucose regulation, and autophagy genes in non-alcoholic fatty liver disease in Wistar rats. Iran J Basic Med Sci. 2022;25:954–63.

PubMed  PubMed Central  Google Scholar 

Hadizadeh F, Faghihimani E, Adibi P. Nonalcoholic fatty liver disease: diagnostic biomarkers. World J Gastrointest Pathophysiol. 2017;8:11.

Article  PubMed  PubMed Central  Google Scholar 

Oh RC, Hustead TR, Ali SM, Pantsari MW. Mildly elevated liver transaminase levels: causes and evaluation. Am Fam Physician. 2017;96:709–15.

PubMed  Google Scholar 

Department of Medical Services M. Guideline on health screening guideline [Internet]. 1st ed. Institute of Medical Research and Technology Assessment; 2022. [cited 2023 Feb 13]. Available from: https://www.dms.go.th/backend//Content/Content_File/Publication/Attach/25650201111409AM_Medical%20Examination%201-02-2022%20final.pdf.

Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W, et al. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord. 2022;22:63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tao L-C, Xu J, Wang T, Hua F, Li J-J. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21:68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, Hernández-González SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95:3347–51.

Article  CAS  PubMed  Google Scholar 

Sakboonyarat B, Poovieng J, Jongcherdchootrakul K, Srisawat P, Hatthachote P, Mungthin M, et al. Rising trends in obesity prevalence among Royal Thai Army personnel from 2017 to 2021. Sci Rep. 2022;12:7726.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sakboonyarat B, Rangsin R, Mittleman MA. Incidence and risk factors of metabolic syndrome among Royal Thai Army personnel. Sci Rep. 2022;12:15692.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu L, Cai Y, Qin R, Zhao B, Li X. Association between triglyceride glucose index and abnormal liver function in both urban and rural Chinese adult populations. Medicine. 2019;98:e18265.

Article  PubMed  PubMed Central  Google Scholar 

Pan X, Yue L, Ren L, Ban J, Chen S. Association of triglyceride-glucose index and liver function parameters among healthy obese civil servants: a center-based study. Diabetes Metab Syndr Obes. 2022;15:3519–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tan EXX, Lee JW-J, Jumat NH, Chan W-K, Treeprasertsuk S, Goh GBB, et al. Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study. Metabolism. 2022;126:154911.

Article  CAS  PubMed  Google Scholar 

Sakboonyarat B, Poovieng J, Jongcherdchootrakul K, Srisawat P, Hatthachote P, Mungthin M, et al. Rising trends in obesity prevalence among Royal Thai Army personnel from 2017 to 2021. Sci Rep Nature Publishing Group. 2022;12:1–8.

Google Scholar 

Sakboonyarat B, Poovieng J, Jongcherdchootrakul K, Srisawat P, Hatthachote P, Mungthin M, et al. Prevalence of hypertriglyceridemia among Royal Thai Army personnel and its related cardiometabolic risk factors, from 2017 to 2021. BMC Public Health. 2022;22:1569.

Article  PubMed  PubMed Central  Google Scholar 

Saito Y, Tanaka A, Node K, Kobayashi Y. Uric acid and cardiovascular disease: a clinical review. J Cardiol. 2021;78:51–7.

Article  PubMed  Google Scholar 

Khalili P, Abdollahpoor S, Ayoobi F, Vakilian A, Hakimi H, Rajabi Z, et al. Evaluation of relationship between serum liver enzymes and hypertension: a cross-sectional study based on data from Rafsanjan Cohort Study. Int J Hypertens. 2022;2022:1–12.

Article  Google Scholar 

Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clin Chem. 2000;46:2027–49.

Article  CAS  PubMed  Google Scholar 

Wroblewski F. The clinical significance of alterations in transaminase activities of serum and other body fluids. Adv Clin Chem. 1958;1:313–51.

Article  CAS  Google Scholar 

Giannini EG. Liver enzyme alteration: a guide for clinicians. Can Med Assoc J. 2005;172:367–79.

Article  Google Scholar 

Armstrong MJ, Houlihan DD, Bentham L, Shaw JC, Cramb R, Olliff S, et al. Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort. J Hepatol. 2012;56:234–40.

Article  PubMed  Google Scholar 

Schindhelm RK, Diamant M, Bakker SJL, van Dijk RAJM, Scheffer PG, Teerlink T, et al. Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus. Eur J Clin Invest. 2005;35:369–74.

Article  CAS  PubMed  Google Scholar 

Esteghamati A, Noshad S, Khalilzadeh O, Khalili M, Zandieh A, Nakhjavani M. Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease. Metab Syndr Relat Disord. 2011;9:111–7.

Article  CAS  PubMed  Google Scholar 

Yu Hua, Haiyue Yu, Shuang Chen et al. The triglyceride glucose index: a novel and effective surrogate marker to identify alanine aminotransferase levels, 12 May 2022, PREPRINT (Version 1) available at Research Square [https://doi.org/10.21203/rs.3.rs-1630090/v1].

Hossain S, Sultana S, Zaman KMdS, Shafiq S, Rahman AKMS, Hossain SMdZ, et al. Triglyceride and glucose Index (TyG) is a reliable biomarker to predict non-alcoholic fatty liver disease. J Biosci Med (Irvine). 2020;08:124–36.

CAS  Google Scholar 

Zhang S, Du T, Zhang J, Lu H, Lin X, Xie J, et al. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis. 2017;16:15.

Article  PubMed  PubMed Central  Google Scholar 

Cartier A, Côté M, Lemieux I, Pérusse L, Tremblay A, Bouchard C, et al. Sex differences in inflammatory markers: what is the contribution of visceral adiposity? Am J Clin Nutr. 2009;89:1307–14.

Article  CAS  PubMed  Google Scholar 

Meyer MR, Clegg DJ, Prossnitz ER, Barton M. Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol. 2011;203:259–69.

Article  CAS  Google Scholar 

Greenhill C. Sex differences in insulin resistance. Nat Rev Endocrinol. 2018;14:65–65.

Article  PubMed  Google Scholar 

Jung H-S, Chang Y, Kwon M-J, Sung E, Yun KE, Cho YK, et al. Smoking and the risk of non-alcoholic fatty liver disease: a cohort study. Am J Gastroenterol. 2019;114:453–63.

Article  PubMed  Google Scholar 

Sakboonyarat B, Poovieng J, Lertsakulbunlue S, Jongcherdchootrakul K, Srisawat P, Mungthin M, et al. Association between raised blood pressure and elevated serum liver enzymes among active-duty Royal Thai Army personnel in Thailand. BMC Cardiovasc Disord. 2023;23:143.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dong MH, Bettencourt R, Barrett-Connor E, Loomba R. Alanine Aminotransferase decreases with age: the Rancho Bernardo study. PLoS ONE. 2010;5:e14254.

Article  PubMed  PubMed Central  Google Scholar 

Gagliano N, Grizzi F, Annoni G. Mechanisms of aging and liver functions. Dig Dis. 2007;25:118–23.

Article  PubMed  Google Scholar 

Guo X, Asthana P, Gurung S, Zhang S, Wong SKK, Fallah S, et al. Regulation of age-associated insulin resistance by MT1-MMP-mediated cleavage of insulin receptor. Nat Commun. 2022;13:3749.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang R, Guan Q, Zhang M, Ding Y, Tang Z, Wang H, et al. Association between triglyceride-glucose index and risk of metabolic dysfunction-associated fatty liver disease: a cohort study. Diabetes Metab Syndr Obes. 2022;15:3167–79.

Article  PubMed  PubMed Central  Google Scholar 

Li X, Li G, Cheng T, Liu J, Song G, Ma H. Association between triglyceride-glucose index and risk of incident diabetes: a secondary analysis based on a Chinese cohort study. Lipids Health Dis. 2020;19:236.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shah J, Okubote T, Alkhouri N. Overview of updated practice guidelines for pediatric nonalcoholic fatty liver disease. Gastroenterol Hepatol (N Y). 2018;14:407–14.

PubMed 

留言 (0)

沒有登入
gif